2022-09-142022-09-142010-03Baytan, B. vd. (2010). "Clofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemia". Journal of Pediatric Hematology Oncology, 32(2), 144-146.1077-41141536-3678https://doi.org/10.1097/MPH.0b013e3181bf298bhttps://journals.lww.com/jpho-online/Fulltext/2010/03000/Clofarabine_induced_Capillary_Leak_Syndrome_in_a.16.aspxhttp://hdl.handle.net/11452/28701Clofarabine has significant efficiency in children with relapsed or refractory leukemia. In previous pediatric trials, various adverse effects have been described. In this case, we report a child with refractory acute lymphoblastic leukemia who developed fatal capillary leak syndrome during clofarabine therapy.eninfo:eu-repo/semantics/closedAccessClofarabineChildrenSystemic capillary leak syndromePhase-IIOncologyHematologyPediatricsAdenine nucleotidesAntineoplastic agentsArabinonucleosidesCapillary leak syndromeChildFemaleHemofiltrationHumansPrecursor cell lymphoblastic leukemia-lymphomaClofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemiaArticle0002755598000162-s2.0-7794946204614414632220057324OncologyHematologyPediatricsClofarabine; Guanine Arabinoside; Acute Lymphoblastic LeukemiaAlbuminAmikacinCeftazidimeClofarabineCyclophosphamideDobutamineDopamineEtoposideGlucoseHemoglobinImmunoglobulinMethylprednisoloneAcute lymphoblastic leukemiaArticleBone marrow suppressionBone marrow transplantationCapillary leak syndromeCase reportChemotherapy induced emesisChildDyspneaFemaleFluid therapyGlucose blood levelHemofiltrationHumanHypoalbuminemiaHypotensionLeukemia remissionMultiple cycle treatmentNauseaNeutrophil countOliguriaOxygen saturationPeriorbital edemaPriority journalSalvage therapySchool childSystemic inflammatory response syndromeTachypneaThrombocyte count